These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Self-reported attitudes of elite athletes towards doping: differences between type of sport. Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338 [TBL] [Abstract][Full Text] [Related]
6. [Sports, use of performance enhancing drugs and addiction. A conceptual and epidemiological review]. Franques P; Auriacombe M; Tignol J Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():37-49. PubMed ID: 11965097 [TBL] [Abstract][Full Text] [Related]
7. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician. Angell PJ; Chester N; Sculthorpe N; Whyte G; George K; Somauroo J Br J Sports Med; 2012 Nov; 46 Suppl 1():i78-84. PubMed ID: 23097484 [TBL] [Abstract][Full Text] [Related]
8. [Medicolegal aspects of doping in sports]. Pruvost J; Depiesse F Ann Readapt Med Phys; 2004 Aug; 47(6):263-73. PubMed ID: 15297116 [TBL] [Abstract][Full Text] [Related]
9. Blood tests in tired elite athletes: expectations of athletes, coaches and sport science/sports medicine staff. Fallon KE Br J Sports Med; 2007 Jan; 41(1):41-4. PubMed ID: 17062653 [TBL] [Abstract][Full Text] [Related]
10. Current anti-doping policy: a critical appraisal. Kayser B; Mauron A; Miah A BMC Med Ethics; 2007 Mar; 8():2. PubMed ID: 17394662 [TBL] [Abstract][Full Text] [Related]
11. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention. Mulcahey MK; Schiller JR; Hulstyn MJ Phys Sportsmed; 2010 Oct; 38(3):105-13. PubMed ID: 20959703 [TBL] [Abstract][Full Text] [Related]
12. Drug testing in elite athletes--the Israeli perspective. Epstein S; Eliakim A Isr Med Assoc J; 1999 Oct; 1(2):79-82. PubMed ID: 10731300 [TBL] [Abstract][Full Text] [Related]
13. Is it legal? Prescribing for the athlete. Sando BG Aust Fam Physician; 1999 Jun; 28(6):549-53. PubMed ID: 10399386 [TBL] [Abstract][Full Text] [Related]
14. Performance-enhancing drug use in young athletes. Laos C; Metzl JD Adolesc Med Clin; 2006 Oct; 17(3):719-31; abstract xii. PubMed ID: 17030288 [TBL] [Abstract][Full Text] [Related]
15. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes]. Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B Sante; 2005; 15(3):167-70. PubMed ID: 16207578 [TBL] [Abstract][Full Text] [Related]
16. Hormone abuse in sports: the antidoping perspective. Barroso O; Mazzoni I; Rabin O Asian J Androl; 2008 May; 10(3):391-402. PubMed ID: 18385901 [TBL] [Abstract][Full Text] [Related]
17. The use of drugs and nutritional supplements in top-level track and field athletes. Tscholl P; Alonso JM; Dollé G; Junge A; Dvorak J Am J Sports Med; 2010 Jan; 38(1):133-40. PubMed ID: 19812387 [TBL] [Abstract][Full Text] [Related]
18. A springtime olympics demands special consideration for allergic athletes. Katelaris CH; Carrozzi FM; Burke TV; Byth K J Allergy Clin Immunol; 2000 Aug; 106(2):260-6. PubMed ID: 10932068 [TBL] [Abstract][Full Text] [Related]
19. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L; Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206 [TBL] [Abstract][Full Text] [Related]